# Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer

> **NCT02985203** · PHASE2 · TERMINATED · sponsor: **Guangdong Association of Clinical Trials** · enrollment: 45 (actual)

## Conditions studied

- Lung Neoplasm Malignant

## Interventions

- **DRUG:** Vinorelbine Oral

## Key facts

- **NCT ID:** NCT02985203
- **Lead sponsor:** Guangdong Association of Clinical Trials
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** No participants were enrolled as schedule.
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02985203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02985203, "Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02985203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*